ArticleBrain & NeuroRehabilitation2026
Short-Latency Afferent Inhibition and Cognitive Function in Older Adults With Mild Cognitive Impairment: A Pilot Study.
Article in Brain & NeuroRehabilitation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Short-latency afferent inhibition (SAI) is a non-invasive measure of cortical cholinergic function, with potential utility as a biomarker for early cognitive decline. However, its relationship to cognitive performance in older adults with mild cognitive impairment (MCI) remains unclear. This cross-sectional study aimed to investigate the association between SAI and cognitive function in older adults with MCI and to explore age-related trends in SAI values. Fifty-seven adults aged ≥ 65 years with MCI were enrolled. SAI was measured using transcranial magnetic stimulation and median nerve stimulation, and the mean value across was used. The highest and lowest motor-evoked potentials from three trials were used to calculate SAI. Cognitive assessments included the Mini-Mental State Examination, Digit Span Forward and Backward, and Trail Making Tests A and B. Participants were grouped by age and by SAI value (< 70% vs. ≥ 70%). Nonparametric methods were used for group comparisons, and Spearman correlations assessed associations between SAI and cognitive scores. No significant associations were observed between SAI values and any cognitive domain. SAI did not differ across age groups. However, 21% of participants showed impaired SAI despite similar cognitive test performance. In this study, SAI was not significantly associated with cognitive performance or age in individuals with MCI. However, impaired SAI in some participants despite similar cognitive scores suggests possible early neurophysiological changes. Longitudinal studies are needed to assess the potential of SAI as a biomarker for preclinical cognitive decline. Trial Registration: Clinical Research Information Service Identifier: KCT0008968.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.